Nature Study: AI Antibody Generation Struggles with Generalization
anshulkundaje · x · 2026-08-21
The AIntibody challenge published in Nature Biotechnology reveals that most AI-native methods struggle to generalize for generating truly developable compounds. The study highlights that binding affinity is not equivalent to efficacy and development, and current intermediate metrics may not benefit patients.
More from Research
- Princeton Paper: Legal Search Benchmarks Fail in Practice, New Dataset Released — burkov · 2026-08-21
- New journal to adopt GEB board, questioning value of legacy publishers — Afinetheorem · 2026-08-21
- HarnessEval-W: An Agentic Benchmark for World Models Evaluation — 青稞AI · 2026-08-21
- GEN-1.5 training for 8+ months shows continuous metric gains via compounding algorithmic advances — ATTlKA · 2026-08-21
- Deep-MKV-TS: Path-Dependent Control for Financial Time Series — chaumian · 2026-08-21
- CrossQ: Task-Aligned Quantization for Late Interaction Retrieval — _reachsumit · 2026-08-21